T he dynamics of ventricular enlargement remain elusive to researchers of hydrocephalus, a disease in which CSF accumulates in the ventricular system. In normal pressure hydrocephalus, the observable CSF flow pathway remains open, yet the ventricles enlarge despite normal intracranial pressure. Continuous monitoring of the disease is difficult for patients with normal pressure hydrocephalus. There remains a lack of research related to the continuous evaluation of intraventricular volume. Thus, the importance of validating a novel volume sensor is crucial to better understanding the pathophysiology of hydrocephalus.
We have recently proposed a method, based on the impedance technique, to measure intraventricular volume change. 4, 23, 24 The measurement principle is based on differences in electrical conductivity (or its inverse impedance) between CSF and brain tissue. If a potential voltage field is generated by 2 excitatory electrodes in the CSFfilled ventricles, the potential decrease at any 2 locations can be measured with additional measurement electrodes typically placed between the 2 excitatory electrodes. The measured potential decrease depends on the electrical properties of the fluid, but is also influenced strongly by surrounding brain tissue, whose conductance is substantially lower than that of CSF. Specifically, the voltage decrease is small when the volume near the sensor is filled with CSF and high when a larger fraction of the space is occupied by poor electrically conducting brain tissue. Accordingly, the voltage measurement is proportional to the size of the fluid-filled volume. Conductance measurements to estimate neuron electrical activity-without exploiting the impedance differences used in volume measurement-have been applied to measure property changes in the lung, 32, 37 thoracic imaging, 6 ,36 blood stroke volume, 19, 34 breast imaging to detect cancer, 10 tissue characterization, 7, 9, 22 and intracranial blood flow. 16, 29, 33 We have demonstrated the feasibility in bench-top models; an animal device implantation study is now shown in this paper to validate the technique.
In the weanling rat hydrocephalic model, sterile ka- Object. Experimental data about the evolution of intracranial volume and pressure in cases of hydrocephalus are limited due to the lack of available monitoring techniques. In this study, the authors validate intracranial CSF volume measurements within the lateral ventricle, while simultaneously using impedance sensors and pressure transducers in hydrocephalic animals.
Methods. A volume sensor was fabricated and connected to a catheter that was used as a shunt to withdraw CSF. In vitro bench-top calibration experiments were created to provide data for the animal experiments and to validate the sensors. To validate the measurement technique in a physiological system, hydrocephalus was induced in weanling rats by kaolin injection into the cisterna magna. At 28 days after induction, the sensor was implanted into the lateral ventricles. After sealing the skull using dental cement, an acute CSF drainage/infusion protocol consisting of 4 sequential phases was performed with a pump. Implant location was confirmed via radiography using intraventricular iohexol contrast administration.
Results. Controlled CSF shunting in vivo with hydrocephalic rats resulted in precise and accurate sensor measurements (r = 0.98). Shunting resulted in a 17.3% maximum measurement error between measured volume and actual volume as assessed by a Bland-Altman plot. A secondary outcome confirmed that both ventricular volume and intracranial pressure decreased during CSF shunting and increased during infusion. Ventricular enlargement consistent with successful hydrocephalus induction was confirmed using imaging, as well as postmortem. These results indicate that volume monitoring is feasible for clinical cases of hydrocephalus.
Conclusions. This work marks a departure from traditional shunting systems currently used to treat hydrocephalus. The overall clinical application is to provide alternative monitoring and treatment options for patients. Future work includes development and testing of a chronic (long-term) volume monitoring system. olin clay is injected into the cisterna magna. This method of inducing hydrocephalus has been shown experimentally to block the reabsorption of CSF, which causes extreme ventricular enlargement. 26 Hydrocephalic rats also approximate the type of ventricular expansion observed in human infants. 15 Much research has also been conducted with this animal model in relating structural and behavioral changes as the disease progresses. 14, 27 Histological measurements show a reduction in ventricular size after shunt treatment in hydrocephalic weanling rats. 13 In a recent study, acute intracranial pressure measurements were obtained in an infusion protocol with hydrocephalic rats. 28 Three-dimensional models of the ventricles in hydrocephalic rats show a 3000% increase in CSF volume compared with baseline in normal rats with a ventricular volume of 10 μl (Fig. 1) . At 14 days after induction of hydrocephalus, 300 μl of CSF accumulates in the ventricular system. At 21 days, the ventricles contain up to 340 μl of CSF. According to the computer-aided sensor design, a 600-μm-outer-diameter sensor with a length of 5 mm is sufficient to fit inside the enlarged ventricles of a hydrocephalic rat after 28 days of induction. We chose the lateral ventricles to implant our sensor, because the surface area of that region is larger than any other part. These ventricles also expand the most during hydrocephalus; therefore, we presumed it to be the most compliant region of the brain suitable for tracking acute CSF volume change.
In this paper, we validate ventricular volume and intracranial pressure measurements in an animal model of hydrocephalus as a first step toward understanding dynamic properties of brain tissue in hydrocephalus. The paper is organized as follows: volume sensor and hardware setup are described first, followed by in vitro calibration with bench-top models. The induction of hydrocephalus and the in vivo experiment are described next. Volume measurements were confirmed independently by imaging the sensor implant system. The results section provides dynamic volume and pressure data with measurement error.
Methods

Sensor Fabrication
The outer diameter of most commercially available volume sensors is approximately 1 mm. The size constraints posed by the hydrocephalic rat model prohibit the use of these commercially available volume sensors. To overcome this limitation, we fabricated miniature sensors sized for the ventricles in hydrocephalic rats. To define the proper size of the sensors, the corresponding ventricular size in hydrocephalic rats was calculated from a stack of MR images that were obtained to create a 3D representation (raw MRI data courtesy of M. R. Del Bigio; Fig. 1 ). The volume sensors were designed using the computeraided design module in Mimics reconstruction software (Materialise) to determine suitable electrode distance and catheter dimensions.
To fabricate our sensor, holes were drilled in a 1-Fr silicone tube using a dicing saw at the Nanotechnology Core Facility at the University of Illinois of Chicago. Wires were passed through these holes to platinum/iridium cylinders (Johnson-Matthey Medical) to create ring electrodes (Fig. 2B ). The total outer diameter of our device was less than 600 μm. Line pressure was measured with a Transpac disposable pressure sensor (ICU Medical). Real-time measurements were collected on a computer using LabVIEW (National Instruments Corporation). The data were sampled at a rate of 10,000 samples/second, with a low-pass eighth-order Butterworth filter applied.
In Vitro Testing (Brain Phantom)
Volume sensors were tested in brain phantoms and silicone balloon models prior to animal testing for calibration. The brain phantom consisted of 0.02% NaCl/0.6% agarose gel to exactly match a brain tissue:CSF electrical conductivity ratio 17 of 12:1. The volumes in the brain phantom cavities ranged from 15 to 150 μl, which were chosen to cover the ventricular volume range in normal to hydrocephalic rats. Measurements were obtained by repeatedly placing the sensor in 4 cavities of the gel. A second in vitro test was performed using a compliant balloon model. The silicone balloon model (DSB detachable silicone balloon, Boston Scientific) was developed to assess the dynamic tracking capabilities of the sensor. The sensor was placed in a silicone balloon whose fluid content could be easily manipulated by adding artificial CSF through a syringe pump (Fig. 3A) . The known relationship between voltage and volume was used to calculate relative CSF volume change in the animal model. Relative volume change was calculated due to unknown properties of CSF in the animal model. The exact geometrical shape of the ventricles, as well as CSF conductivity values, was unknown. The constraints of using the bench model for calibration of the sensor are described in the discussion section below.
In Vivo Testing (Hydrocephalic Rat)
Animal experiments were approved by the Animal Care and Use Committee at the University of Illinois at Chicago. An acute experiment was designed that consisted of sequential shunting and infusing CSF from the ventricles of a hydrocephalic rat. The objective was to measure dynamic volume changes. Animals were weighed prior to induction of hydrocephalus and regularly throughout the experimental end point. Fifteen 3-weekold Sprague-Dawley rats were injected with 20 μl of 25% w/v sterile kaolin suspension into the cisterna magna using a 26-gauge needle. The animals were allowed to recover from anesthesia and were closely monitored after injection. Weights of kaolin-injected animals were compared with the weights of control animals; kaolin-injected animals exhibiting qualitatively retarded weight gain, a dome-shaped head, and gait instability were considered hydrocephalic, 21 and hydrocephalus was quantitatively verified postmortem.
Four weeks following the induction of hydrocephalus in the rats, we implanted the sensor and obtained measurements during controlled CSF drainage (shunting) and infusion using a pump (Fig. 2) . In each hydrocephalic rat, a bur hole was made, and the sensor was stereotactically implanted in the lateral ventricle 8.0-mm anterior, 1.5-mm medial, and 4.0-to 6.0-mm ventral to the lambda. 30 Dental cement was applied over the bur hole to prevent fluid leakage. A sequential CSF shunting and infusion protocol was performed with rates within range of normal rat CSF production of 3-5 μl/min. 25 Shunting and infusion were performed to match physiological parameters. In our protocol, CSF was first shunted at 3 μl/min for 10 minutes, infused at 6 μl/min for 15 minutes, shunted at 3 μl/min for 15 minutes, and finally infused at 30 μl/min for 4 minutes to observe a rapid volume change. Rates were maintained with a syringe pump (Harvard Apparatus), and data were collected using LabVIEW software. Immediately following the experiment, the animals were killed, and their brains were fixed in 10% formalin.
Radiographic Imaging
Radiography with contrast administration was performed in 1 hydrocephalic and 1 nonhydrocephalic animal to assess the location of the implant, as well as to discern ventricle integrity during implantation. Radiographic imaging with intraventricular contrast administration was recently suggested for clinical diagnosis of occluded ventricles. 18 Sixty microliters of 250 mg/ml iohexol contrast agent was injected through the shunt, and a radiographic imaging system (Philips Integris V3000) was used. Twodimensional dynamic images were obtained at a frame rate of 0.5 frames/second at the highest resolution of 100 μm per pixel.
Statistical Analysis
The Pearson correlation coefficient and a BlandAltman plot 8 were computed using MATLAB (The MathWorks, Inc.).
Results
In vitro calibration of the volume sensor in a balloon model demonstrated sensitivity of 0.1 mV/ml (Fig. 3A) . The relative change in voltage measured by the sensor is more accurate at smaller volumes. Furthermore, the validation of the volume sensors in the balloon model showed a strong correlation (r = 0.98; Fig. 3B ). A decrease in line pressure of 45 mm Hg occurred as volume decreased; the nonlinear trend indicated independent pressure-volume measurements (Fig. 3C) .
When CSF was shunted from the hydrocephalic rats, voltage increased consistent with the observations made previously in the in vitro bench-top experiments. The opposite trend was observed when fluid was infused back into the ventricles. Phase 1 consisted of first shunting the hydrocephalic animals at 3 μl/min for 10 minutes to reduce CSF volume. The next procedure (Phase 2) consisted of infusing CSF back into the ventricles at a slightly higher rate of 6 μl/min for 15 minutes. Phase 3 consisted of shunting CSF from the ventricles again at a rate of 3 μl/min, this time for 15 minutes. In Phase 4, we infused at a high flow rate of 30 μl/min for 4 minutes. Prior to the shunting and infusion protocols, drift measurements were obtained during hardening of the dental cement. Drift was defined as deviation of measurement from non-volume change; drift was found to be minimal and was less than 2% of the voltage measurement. Results were plotted using MATLAB with a moving average filter. Voltage data were acquired at a rate of 10,000/second; samples were reduced to trim the size of the data record. Calibration obtained from the in vitro experiments was applied to each data set to convert the voltage measurements into relative volume.
Shunting Accuracy
Measurements of CSF volume reduction for the assessment of treatment efficacy must maintain high accuracy. The actual volumes obtained during shunting of the hydrocephalic rats were plotted against the measured volume for Phases 1 and 3 (Fig. 4) . The Pearson correlation coefficients during the CSF shunting (Phases 1 and 3) were r = 0.99 and 0.98, respectively. The measurement error was plotted as a function of the volume decrease (Fig.  5 ). The mean difference between the sensor-measured volume and volume controlled using a syringe pump was 4.6 μl. The measurement error calculated from total volume removed and final measured volume was 17.3%. These particular sensors are most accurate for fluid removal in the range of 0-10 μl.
Fluid Addition
The effect of CSF infusion (Phases 2 and 4) presumably restored ventricular size to some degree. However, measurements (data not depicted) were less accurate with an error of 75%, but the Pearson correlation coefficients of r = 0.97 (Phase 2) and 0.98 (Phase 4) continued to exhibit a strong correlation.
Independent Ventricular Size Determination by Imaging
A bur hole created in a hydrocephalic skull immediately resulted in CSF leakage. Dental acrylic was applied to the bur hole immediately after sensor implantation (Fig.  6 left) , but the shape of the ventricles was in question during the shunting/infusion protocol. Radiographic imaging with contrast administration allowed for an independent assessment of ventricular shape after implantation (Fig.  6 right) . Sensor measurements were also obtained during imaging, but the electrical conductivity of iohexol altered the measurement and results are not shown.
Previous studies of the gross morphology of hydrocephalus induced by kaolin injection into the cisterna magna have found residual kaolin in the subarachnoid space, on the ventral surface of the brain, and in the cisterna magna. 27 We noticed during imaging that the infused iohexol traveled down spinal CSF more rapidly than the ventricle expanded. This phenomenon might be related to the transportation of contrast agent through the entire CSF space, including the spinal region, rather than being an exclusive event limited to the cranial ventricular system. The hydrocephalic animal may have had communicating ventricles, without obstruction in the CSF pathway.
Fifteen animals were intracisternally injected with kaolin. Six animals were removed from the study due to severe neurological impairment caused by possible brainstem injury or intraventricular hemorrhage. Of the remaining animals, 5 displayed symptoms of hydrocephalus; this was confirmed postmortem, with cross-sections that showed increasing severity of ventriculomegaly (Fig.  7) . Gross enlargement of the ventricles with compression of cortex adjacent to the ventricles was observed. Bleeding occurred during sensor implantation in 1 animal, which affected the sensor measurements.
Discussion
The current clinical treatment for patients with hydrocephalus involves placing a catheter inside cerebral ventricles to shunt CSF. Many problems occur related to treatment, such as overdrainage and the need for shunt revisions. Pressure-regulated shunts are often ineffective for patients with normal pressure hydrocephalus. Daily pressure changes coupled with the small pressure noted in normal pressure hydrocephalus can cause overdrainage, resulting in excess CSF removal, causing subdural effusions or hemorrhage. There are innovative systems such as the commercially available flow-based shunt (Orbis-Sigma valve, Integra). Another commercially available device can be adjusted using external magnetic fields (Strata valve, Medtronic). However, at a 2010 Hydrocephalus Meeting in Cleveland, many clinicians and patients expressed dissatisfaction due to the Strata valve's sensitivity to magnetic fields and the frequent need for revisions. 35 Even toy magnets have been shown to disrupt adjustable shunt settings. 2 Between 6% and 12% of children with shunts develop slit ventricle syndrome due to overshunting. 31 In a survey of pediatric neurosurgeons who routinely implant shunts into children with hydrocephalus, the majority expressed their inability to prevent slit ventricle syndrome. 1 Researchers have developed pioneering systems such as the capacitive intracranial pressure sensors 3 or the microvalves for shunts, 11 but there are currently no devices to continuously monitor ventricular volume directly.
In vitro bench-top validation experiments provided a test bed for optimizing sensor parameters and proved superior over trial-and-error animal experimentation. We have used bench-top validation experiments in the past to create calibration data, as well as sensitivity analysis. For instance, sensitivity with sensor proximity to the ventricle wall has been measured previously in agarose bench-top models. In those experiments, the sensor was placed in different cavities with increasing volume, with variable distance to the boundary. Also, variations of CSF fluid conductivity were tested by adjusting the salt content.
Our in vivo validation experiments demonstrate dynamic measurements of CSF volume and pressure in a hydrocephalic animal. The CSF volume was controlled in the ventricles of a hydrocephalic rat using a syringe pump, while local intraventricular volume and pressure were recorded simultaneously. The volume sensor was designed and fabricated using computer-aided design principles on 3D reconstructions of the rat brain. Acute measurements of volume and pressure change were performed as a first step toward understanding volume and pressure, or compliance, in hydrocephalus. The in vivo sensor measurements due to shunting at similar CSF production rates are precise. The sensor detected 30-35 μl of volume change in Phase 1, which is comparable to the 30 μl of volume removed using the syringe pump. In Phase 3, the sensor detected a 25-to 45-μl volume change due to shunting 45 μl of CSF.
When an acute shunting procedure with constant flow rates is performed at different stages of hydrocephalus, ventricular size reduction may not be possible. The properties of the brain tissue, such as tissue compliance, are not well known. The high incidence of shunt failure warrants further study of CSF removal rate, tissue compliance, and volume change. Future experiments will use models with larger animals with a chronic, wireless, volume-pressure monitoring system. These measurements, coupled with high-resolution MRI, may allow for longterm studies of brain tissue.
We acknowledge that the calibration experiments use simple geometry. Future experiments consist of performing 3D reconstruction of the ventricles before and after shunting to improve the calibration curve using high-resolution MRI. This procedure may improve the accuracy of the measurements and also allow for measuring absolute volume as opposed to relative volume change.
The electrical conductivity ratio between CSF and brain tissue is 12:1 in the normal state. 5 However, the conductivity of CSF and brain tissue during hydrocephalus may change. This alteration may be caused by hemorrhage, and some researchers have shown that protein concentration levels change during hydrocephalus. 12 To date, the changes in electrical conductivity during hydrocephalus have not been measured to the best of our knowledge. However, the changing conductivity should be small compared with the measurements caused by large volume expansion; therefore, this is not expected to significantly impact the precision of the measurement.
During fluid addition, the larger measurement error between measurement and fluid addition is related to the fact that CSF infusion into hydrocephalic ventricles was associated with CSF leakage around the implanted sensor. This point is further confirmed by the relationship of the recorded pressure and volumes infused, in which there was an unexpected plateau of the pressure as volume continued to be infused, a phenomena that can only be explained by CSF leakage around the sensor. Despite our rigorous efforts to seal the bur hole with dental cement, a small amount of fluid may still have leaked into the gap space. Another possible explanation is that an obstruction at the tip of the catheter prevented fluid from entering the ventricular system. Obstruction during infusion remains a persistent problem. 20 
Conclusions
This experiment validates a method to measure dynamic changes in ventricular volume using impedance sensors. Two phenomena were observed: CSF volume can be controlled acutely from the ventricles of a hydrocephalic rat, and local dynamic volume and pressure changes can be recorded. Ventricular volume was controlled using a shunting/infusion protocol with a syringe pump. The successful induction of hydrocephalus via kaolin injection was confirmed postmortem. Future work involves measuring volume change in a hydrocephalic animal using long-term implanted sensors and implanted electronics with wireless capability.
Volume and pressure monitoring is intended to provide tools for researchers of hydrocephalus where compliance research and shunt efficacy are concerned. These dynamic measurements are expected to provide alternative monitoring and treatment options for patients with hydrocephalus.
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